Table 5.
Adjusted ORs: Correlates of thrombotic and thromboembolic events in individuals with diabetes with suspected or confirmed COVID-19
| Characteristic | Adjusted OR (95% CI)* | Q value |
| Diabetes status | ||
| Type 1 diabetes | 1 (Reference) | |
| Type 2 diabetes | 0.84 (0.72 to 0.98) | 0.005 |
| Haemoglobin A1c (%)† | 1.05 (1.04 to 1.07) | <0.001 |
| Age (years) | ||
| 18–29 | 1 (Reference) | |
| 30–39 | 2.02 (1.32 to 3.10) | <0.001 |
| 40–49 | 3.47 (2.33 to 5.17) | <0.001 |
| 50–59 | 4.76 (3.22 to 7.04) | <0.001 |
| 60–69 | 6.23 (4.21 to 9.21) | <0.001 |
| 70–79 | 7.39 (5.00 to 10.94) | <0.001 |
| 80+ | 7.71 (5.20 to 11.43) | <0.001 |
| Sex | ||
| Female | 1 (Reference) | |
| Male | 1.22 (1.15 to 1.28) | <0.001 |
| Race and ethnicity | ||
| NHW | 1 (Reference) | |
| NHB | 1.02 (0.94 to 1.11) | 0.077 |
| Hispanic | 0.91 (0.84 to 0.98) | 0.002 |
| AAPI | AIAN | NHO | 1.11 (1.00 to 1.24) | 0.008 |
| BMI (kg/m2) | ||
| 18.5–24.9 | 1 (Reference) | |
| <18.5 | 1.16 (0.95 to 1.41) | 0.024 |
| 25.0–29.9 | 0.97 (0.90 to 1.05) | 0.063 |
| 30.0–34.9 | 0.94 (0.87 to 1.02) | 0.025 |
| 35.0–39.9 | 0.88 (0.80 to 0.97) | 0.002 |
| ≥40.0 | 0.85 (0.77 to 0.94) | <0.001 |
| History of TTE | ||
| Not present | 1 (Reference) | |
| Present | 2.23 (2.12 to 2.36) | <0.001 |
*Unadjusted ORs are found in online supplemental table 14.
†Haemoglobin A1c was analysed as a continuous variable.
AAPI | AIAN | NHO, Asian American/Pacific Islander, American Indian/Alaska Native, non-Hispanic Other; BMI, body mass index; NHB, non-Hispanic Black; NHW, non-Hispanic White; TTE, thrombotic or thromboembolic event.